Last update 19 Apr 2025

DB-1305

Overview

Basic Info

Drug Type
Antibody drug conjugate (ADC)
Synonyms
BNT 325, BNT-325, BNT325
+ [1]
Action
inhibitors
Mechanism
TOP1 inhibitors(DNA topoisomerase I inhibitors), Trop-2 inhibitors(Tumor-associated calcium signal transducer 2 inhibitors)
Inactive Indication-
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
RegulationFast Track (United States)
Login to view timeline

Structure/Sequence

Boost your research with our ADC technology data.
Boost your research with our ADC technology data.

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Head and Neck NeoplasmsPhase 2
United States
19 Jul 2022
Head and Neck NeoplasmsPhase 2
China
19 Jul 2022
Head and Neck NeoplasmsPhase 2
Puerto Rico
19 Jul 2022
Mesothelioma, MalignantPhase 2
United States
19 Jul 2022
Mesothelioma, MalignantPhase 2
China
19 Jul 2022
Mesothelioma, MalignantPhase 2
Puerto Rico
19 Jul 2022
Metastatic castration-resistant prostate cancerPhase 2
United States
19 Jul 2022
Metastatic castration-resistant prostate cancerPhase 2
China
19 Jul 2022
Metastatic castration-resistant prostate cancerPhase 2
Puerto Rico
19 Jul 2022
Metastatic Solid TumorPhase 2
United States
19 Jul 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
44
DB-1305
vqgvprtxat(nlbbxvhzeo) = Three patients dosed at 6 mg/kg experienced dose-limiting toxicities (i.e., stomatitis, febrile neutropenia, and white blood cell decreased), and the maximum tolerated dose was established as 5 mg/kg. lnezcuavzr (nllexnundk )
Positive
23 Oct 2023
DB-1305
(NSCLC)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free